Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295354
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2024-02-26
Brief Title:
Early Variations in Immune Aging
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Study Overview
Official Title:
Early Variations in Immune Aging
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EVIA-NL
Brief Summary:
Background
Despite an increase in lifespan over the last decades our healthspan lags behind In our aging population it is pressing that we prevent age-related morbidities and associated burden on the health care system Instead of investigating aging in already aged populations the currently proposed study aims to elucidate the process of immune aging in relation to biological aging demographic and lifestyle factors in young and midlife adults and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes
Study design
A single-center observational prospective cohort study in the Netherlands Participants from priorly established cohorts will be invited to join the EVIA-study We will obtain demographic and basic clinical data and biological samples blood and stool at baseline and after three years with a short yearly online questionnaire in between
Despite an increase in lifespan over the last decades our healthspan lags behind In our aging population it is pressing that we prevent age-related morbidities and associated burden on the health care system Instead of investigating aging in already aged populations the currently proposed study aims to elucidate the process of immune aging in relation to biological aging demographic and lifestyle factors in young and midlife adults and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes
Study design
A single-center observational prospective cohort study in the Netherlands Participants from priorly established cohorts will be invited to join the EVIA-study We will obtain demographic and basic clinical data and biological samples blood and stool at baseline and after three years with a short yearly online questionnaire in between
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None